Bepridil (trade name Vascor) is an diamine calcium channel blocker once used to treat angina pectoris.

[2] It has been implicated in causing ventricular arrhythmia (torsades de pointes).

In June 2015 a research paper [3] was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.

[4] A research paper [5] showed that Bepridil inhibited cytopathogenic effects induced by SARS-CoV-2 in Vero E6 cells and in A549 cells in an in vitro assay.

This drug article relating to the cardiovascular system is a stub.